Methotrexate Rosemont Pharmaceuticals (Methotrexate Disodium)

Methotrexate blocks the enzyme dihydrofolate reductase, which is essential for converting folate into its active form. This interruption limits the production of nucleotides needed for DNA and RNA synthesis, thereby reducing the proliferation of rapidly dividing cells such as immune cells and cancer cells.

The dose of Methotrexate Rosemont is individualized by the prescribing clinician based on the specific indication, patient weight, renal and hepatic function, and response to therapy. No universal dosing regimen is provided; the prescriber sets the appropriate amount and schedule.

Methotrexate is classified as Pregnancy Category X, meaning it is contraindicated during pregnancy because it can cause fetal malformations and loss. It is also not recommended while breastfeeding, as it may be excreted in milk and affect the infant.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Methotrexate is often considered the first‑line disease‑modifying antirheumatic drug because of its proven efficacy, oral administration, and relatively low cost compared with biologic agents. Other DMARDs, such as leflunomide or sulfasalazine, may be used when methotrexate is ineffective or not tolerated, but they have different safety profiles and monitoring requirements.

Store the product at ambient temperature, preferably below 25 °C. Keep the tablets in their original container, protect them from moisture and direct sunlight, and ensure the packaging remains tightly closed until use.

Methotrexate Rosemont is taken orally as a tablet. The exact dosing schedule—such as weekly dosing versus daily low‑dose regimens—depends on the indication and the prescriber’s instructions. Patients should swallow the tablet with water and follow any specific guidance regarding food intake.

The most serious risks include severe liver toxicity, pulmonary fibrosis, profound bone‑marrow suppression leading to pancytopenia, and opportunistic infections. Patients should report signs such as persistent fatigue, unusual bruising, shortness of breath, or jaundice to their healthcare provider promptly.

Methotrexate is contraindicated in individuals who are pregnant, planning to become pregnant, or breastfeeding. It should also be avoided in patients with severe hepatic impairment, significant renal dysfunction, uncontrolled infections, or known hypersensitivity to methotrexate or any of its excipients.